Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.
Press releases published on June 27, 2025
2025 Du Bois Forum & Statue Unveiling: Celebrated Gathering of Writers, Scholars, & Artists Returns to the Berkshires
EIN Presswire
·
June 27, 2025
The Du Bois Forum is pleased to announce its fourth annual gathering, set to take place July 18-20, 2025. GREAT BARRINGTON, MA, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- The Du Bois Forum, an annual retreat and year-round fellowship dedicated …
Riendeau-Mulvey Funeral Home and Memorial Cremation Continue a 150-Year Legacy of Care in Taunton
EIN Presswire
·
June 27, 2025
Locally owned and operated, the historic funeral home remains a trusted source of affordable funeral and cremation services across Southeastern Massachusetts. TAUNTON, MA, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- With roots dating back to 1869 …
empatiX Consulting is Moving for Amirah Once Again
EIN Presswire
·
June 27, 2025
The consultancy continues its support and commitment to end human trafficking through the support of the Move for Amirah foundation BOSTON, MA, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- empatiX Consulting is proud to announce that it is …
Biosimilars Market on the Rise: Expected 19.4% CAGR Over Next Five Years
GlobeNewswire
·
June 27, 2025
Boston, June 27, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biosimilars: Global Markets” is expected to grow from $28.5 billion in 2024 to $69.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.4% …
New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA
GlobeNewswire
·
June 27, 2025
New analyses from DEVOTE Part C further characterize the improvements in motor function in participants with SMA who transitioned to the investigational higher dose regimen of nusinersen from 12 mg SPINRAZA® (nusinersen) Final results from the landmark …
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
June 27, 2025
WATERTOWN, Mass., June 27, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic …
Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer
GlobeNewswire
·
June 27, 2025
BOSTON, June 27, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that the first patient has been dosed in …
Kymera Therapeutics Announces Pricing of $250 Million Public Offering
GlobeNewswire
·
June 27, 2025
WATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing …